CTLA4 and neoplasm: Most of these investigations employed circulating T cells, due to the difficulty of obtaining longitudinal tumor samples, nevertheless TCR profiling of infiltrating T cells is also emerging, highlighting the different impact on TCR diversity exerted by the mAbs targeting the two major ICIs, namely CTLA-4 and PD-1 [92].